Third- or second-generation parathyroid hormone assays: A remaining debate in the diagnosis of primary hyperparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 12, 2005, Pages 6370-6372

  Boudou, Philippe ^a   Ibrahim, Fidaa ^a   Cormier, Catherine ^b   Chabas, Almécinda ^a   Sarfati, Emile ^a   Souberbielle, Jean Claude ^c  

^a SAINT LOUIS HOSPITAL   (France)

^b Assistance Publique Hôpitaux de Paris ^*  (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ENDOCRINE SURGERY; FEMALE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; TIME SERIES ANALYSIS;

AGED; ENDOCRINOLOGY; FEMALE; HUMANS; HYPERPARATHYROIDISM; IMMUNOLOGIC TECHNIQUES; MALE; MIDDLE AGED; PARATHYROID HORMONE; SENSITIVITY AND SPECIFICITY;

EID: 28744435195     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-0715     Document Type: Article

References (13)

1. Nussbaum S, Zahradnik R, Lavigne J, Brennan G, Nozawa-Ung K, Kim L, Keutmann H, Wang CH, Potts J, Segre G 1987 Highly sensitive two-site immunoradiometric assay for parathyrin and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33:1364-1367
2. Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, D'Amour P 1998 A non (1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44:805-809
3. John M, Goodman W, Gao P, Cantor T, Salusky I, Jüppner H 1999 A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implication for PTH measurements in renal failure. J Clin Endocrinol Metab 84:4287-4290
4. Gao P, Scheibel S, D'Amour P, John M, Rao S, Schmdt-Gayk H, Cantor T 2001 Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 16:605-614
5. Silverberg S, Gao P, Brown I, LoGerfo P, Cantor T, Bilezikian J 2003 Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism. J Clin Endocrinol Metab 88:4725-4730
6. Carnevale V, Dionisi S, Nofroni I, Romagnoli E, Paglia F, De Geronimo S, Pepe J, Clemente G, Tonnarini G, Minisola S 2004 Potential utility of a new IRMA for parathyroid hormone in postmenopausal patients with primary hyperparathyroidism. Clin Chem 50:626-631
7. Inaba M, Nakatsuka K, Imananishi Y, Watanabe M, Mamiya Y, Ishimura E, Nishizawa Y 2004 Technical and clinical characterization of the bio-PTH (1-84) immunochemiluminometric assy and comparison with a secon generation assay for parathyroid hormone. Clin Chem 50:385-390
8. Bilezikian JP, Potts Jr JT, Fuleihan Gel-H, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells Jr SA 2002 Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 17:N2-N11
9. Holick M 2003 The parathyroid hormone D-lemna. J Clin Endocrinol Metab 88:3499-3500
10. Reichel H, Esser A, Roth HJ, Schmidt-Gayk H 2003 Influence of PTH assay methodology on differential diagnosis of renal bone disease. Nephrol Dial Transplant 18:759-768
11. Koller H, Zitt E, Staudacher G, Neyer U, Mayer G, Rosenkranz A 2004 Variable parathyroid hormone (1-84)/carboxyl-terminal PTH ratios detected by 4 novel parathyroid hormone assays. Clin Nephrol 61:337-343
12. Cantor T, Glowacki P, Scheibel S 2003 Large differences between commercial intact PTH assays. J Am Soc Nephrol 14:SU698
13. Souberbielle JC, Cormier C, Kindermans C, Gao P, Cantor T, Forette F, Baulieu EE 2001 Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 86:3086-3090